2014
DOI: 10.1016/j.ijpharm.2013.11.030
|View full text |Cite
|
Sign up to set email alerts
|

Thermosensitive hydrogels of poly(methyl vinyl ether-co-maleic anhydride) – Pluronic® F127 copolymers for controlled protein release

Help me understand this report

Search citation statements

Order By: Relevance

Paper Sections

Select...
2
2
1

Citation Types

1
30
0
1

Year Published

2015
2015
2021
2021

Publication Types

Select...
4
3

Relationship

1
6

Authors

Journals

citations
Cited by 71 publications
(32 citation statements)
references
References 34 publications
1
30
0
1
Order By: Relevance
“…The capability to control the quantity, location and time of drug dosing is one of the main objectives in the design of drug delivery systems (37). For these purposes systems responsive to different stimulus, such as temperature, pH or light among others have been prepared (38)(39)(40)(41). A light triggered MN drug delivery system have been designed and successfully tested in vitro for the release of a clinical relevant model drug: ibuprofen.…”
Section: Discussionmentioning
confidence: 99%
“…The capability to control the quantity, location and time of drug dosing is one of the main objectives in the design of drug delivery systems (37). For these purposes systems responsive to different stimulus, such as temperature, pH or light among others have been prepared (38)(39)(40)(41). A light triggered MN drug delivery system have been designed and successfully tested in vitro for the release of a clinical relevant model drug: ibuprofen.…”
Section: Discussionmentioning
confidence: 99%
“…Due to their temperature-responsive behavior, these are also known as thermosensitive polymers. 175,[192][193][194][195] These polymers are inert in nature and are known to maintain the stability of incorporated therapeutic proteins and peptides with an increase in their survival period as compared to other sustained release drug delivery systems. 145,196,197 Other than having the efficient property to deliver therapeutic substances to the targets, these polymers have a diverse range of applications.…”
Section: Poly(lactic-co-glycolic Acid)mentioning
confidence: 99%
“…196,217,236 Pharmaceutical scientists have tried to evade this limitation of PF127 by making few physical and chemical modifications using other biodegradable polymers which may increase the residence time and mechanical properties that ultimately help prolong the sustained release of incorporated therapeutic proteins for a longer period of time compared to PF127 alone. 195,229,[237][238][239] Mechanical strength and the bioadhesive properties of PF127 have been also increased by conjugating PF127 with other mucoadhesive polymers. 44,226,240,241 2.2.5.…”
Section: Poly(lactic-co-glycolic Acid)mentioning
confidence: 99%
“…Numerous methods were successively developed for preparing TVPs to endow polymer solutions with thermothickening ability, besides graft modification in organic solvent, free radical copolymerization in bulk monomers, or different media such as aqueous solution, dodecane dispersion, micellar solution were also developed. In addition, the living radical polymerization was also employed to synthesize TVPs.…”
Section: Introductionmentioning
confidence: 99%
“…The materials with high content of macromonomer (>35%) were easily obtained. However, the existing free radical preparation methods still have their own disadvantages: first, the weight‐average molecular weight ( M w ) of TVPs reported to date is just up to 3.8 × 10 6 g·mol −1 , and the “thermothickening” effect could only be got at much high concentrations (1–5 wt %); second, the final solutions after polymerization always had high viscosity and even turned into gels, which induced a tough post processing; third, the strict condition of living radical polymerization is not suitable for industrial applications. These disadvantages not only impeded scaled‐up manufacturing of TVPs, but also limited their practical application.…”
Section: Introductionmentioning
confidence: 99%